Evidence map›Paper›PMID 36589521›Full record

ArticleMolecular genetics, microbiology and virology : Molekulyarnaya genetika, mikrobiologiya i virusologiya2022

Oral Delivery of SARS-CoV-2 DNA Vaccines Using Attenuated

Dan Zhu, Mengyue Mengyue, Aaodeng Qimuge, Bilige Bilige, Tegexi Baiyin, Temuqile Temuqile, Shana Chen, Siqin Borjigen, Huricha Baigude, Dezhi Yang

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular genetics, microbiology and virology : Molekulyarnaya genetika, mikrobiologiya i virusologiya, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Live-AttenuatedVaccines · 2023
    Article
  6. Article
  7. Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Dan ZhuPharmaceutical Laboratory, Inner Mongolia International Mongolian Hospital, 010065 Hohhot, Inner Mongolia China.
Mengyue MengyuePharmaceutical Laboratory, Inner Mongolia International Mongolian Hospital, 010065 Hohhot, Inner Mongolia China.
Aaodeng QimugePharmaceutical Laboratory, Inner Mongolia International Mongolian Hospital, 010065 Hohhot, Inner Mongolia China.
Bilige BiligePharmaceutical Laboratory, Inner Mongolia International Mongolian Hospital, 010065 Hohhot, Inner Mongolia China.
Tegexi BaiyinPharmaceutical Laboratory, Inner Mongolia International Mongolian Hospital, 010065 Hohhot, Inner Mongolia China.
Temuqile TemuqilePharmaceutical Laboratory, Inner Mongolia International Mongolian Hospital, 010065 Hohhot, Inner Mongolia China.
Shana ChenPharmaceutical Laboratory, Inner Mongolia International Mongolian Hospital, 010065 Hohhot, Inner Mongolia China.
Siqin BorjigenPharmaceutical Laboratory, Inner Mongolia International Mongolian Hospital, 010065 Hohhot, Inner Mongolia China.
Huricha BaigudeSchool of Chemistry and Chemical Engineering, Inner Mongolia University, 010020 Hohhot, Inner Mongolia China.
Dezhi YangPharmaceutical Laboratory, Inner Mongolia International Mongolian Hospital, 010065 Hohhot, Inner Mongolia China.
Inner Mongolia International Mongolian Hospital · CNInner Mongolia University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 2019 novel coronavirus disease (COVID-19) is the disease that has been identified as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but the prophylactic treatment of SARS-CoV-2 is still under investigation. The effective delivery of eukaryotic expression plasmids to the immune system's inductive cells constitutes an essential requirement for generating effective DNA vaccines. Here, we have explored the use of

Indexed as

antibody responseDNA vaccineoral vaccineSalmonella typhimuriumSARS-CoV-2

Identifiers

PMID36589521
PMCPMC9790184
OpenAlexW4312434796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.